Kangpei Biotech Announces Board Resolution on Issuance of Restricted Stock Units for 2025 Fiscal Year

1. Event Date: June 26, 2026 2. Company Name: Kangpei Biotech Co., Ltd. 3. Relationship with Company: Parent Company 4. Cross-shareholding Ratio: Not applicable 5. Reason for Event: (1) The issuance was approved by the 2025 Annual General Meeting and authorized by the Financial Supervisory Commission of the Executive Yuan under document number JGZ-1140349351 dated July 4, 2025. (2) The board of directors resolved on June 26, 2026, to issue 23,000 restricted stock units for the 2025 fiscal year, with a par value of NT$0.5 per share. The capital increase base date is June 26, 2026. Any adjustments due to operational changes will be delegated to the Chairman. (3) All restrictions, key agreements, and supplementary matters related to the issuance shall be governed by relevant laws and regulations and the company's "2025 Restricted Stock Unit Issuance Guidelines." 6. Mitigation Measures: None 7. Other Disclosures: This announcement qualifies as material information under Article 7, Paragraph 9, Clause 9 of the Enforcement Rules of the Securities and Exchange Act, if applicable to publicly issued companies, but no additional matters are currently required.